The alterations in the gut microbiota have also been shown to contribute to the development of NAFL/NASH by mediating inflammation, insulin resistance, bile acid secretion, and choline metabolism, among others (20). This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.